Related Experiment Videos
Augmenting effect of opioid peptides on murine macrophage activation
Abstract:
We investigated the effect of several opioid peptides on the activation of murine peritoneal exudate macrophages (M phi) in vitro. M phi were treated with interferon (IFN) as a priming agent and bacterial lipopolysaccharide (LPS) as a triggering agent in the presence or absence of opioid peptides. M phi activation was assessed by their tumoricidal activity. When treatment with IFN and LPS resulted in a high level activation of M phi, dynorphin-A exerted no further enhancing effect. When treatment induced only weak activation, however, dynorphin-A augmented the M phi activation. Leucine-enkephalin, methionine-enkephalin, and also beta-endorphin had augmenting effects. An opioid receptor antagonist, naloxone, reduced the effect of dynorphin-A and beta-endorphin. When M phi were treated sequentially with IFN and LPS, beta-endorphin operated in combination with LPS only. Moreover, beta-endorphin was effective for already activated M phi. These results indicate that opioid peptides act on M phi via classical opioid receptors, and that responsiveness to opioid peptides is induced in the triggering stage of M phi activation.
Insights
Opioid peptides like dynorphin-A and beta-endorphin enhance macrophage activation. This effect is mediated via opioid receptors and is most pronounced during the triggering stage of macrophage activation.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Macrophages are key immune cells involved in host defense.
- Opioid peptides are known for their roles in pain modulation and mood regulation.
- The interaction between opioid peptides and macrophage activation is not fully understood.
Purpose of the Study:
- To investigate the in vitro effects of various opioid peptides on murine peritoneal exudate macrophages (M phi).
- To determine the role of opioid receptors in mediating these effects.
- To elucidate the stage of macrophage activation at which opioid peptides exert their influence.
Main Methods:
- Murine peritoneal exudate macrophages (M phi) were primed with interferon (IFN) and triggered with bacterial lipopolysaccharide (LPS).
- The tumoricidal activity of M phi was assessed to measure activation.
- Opioid peptides (dynorphin-A, leucine-enkephalin, methionine-enkephalin, beta-endorphin) and an opioid receptor antagonist (naloxone) were used.
- Sequential treatment protocols were employed to study timing effects.
Main Results:
- Dynorphin-A augmented M phi activation when initial activation by IFN and LPS was weak.
- Leucine-enkephalin, methionine-enkephalin, and beta-endorphin also showed augmenting effects.
- Naloxone reduced the effects of dynorphin-A and beta-endorphin, indicating opioid receptor involvement.
- Beta-endorphin was effective only in combination with LPS and on already activated M phi.
Conclusions:
- Opioid peptides modulate macrophage activation through classical opioid receptors.
- Macrophage responsiveness to opioid peptides is induced during the triggering phase of activation.
- These findings suggest a potential role for opioid peptides in immune regulation.